ArticleAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2025
A Facile Strategy to Restore the Optic Nerve Functionality Using an Injectable Conducting Hydrogel.
Article in Advanced science (Weinheim, Baden-Wurttemberg, Germany), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Hierarchical ROS-scavenging hydrogel system for coordinating the modulation of RGC necroptosis and oxidative stress in an acute glaucoma model.Bioactive materials · 2026Article
- Extrinsic Regulation of Optic Nerve Axon Regeneration in the Adult Central Nervous System.Cells · 2026Review
- PEDOT:PSS in peripheral nerve injury repair: electrical stimulation, neural interfaces, and neural regenerative mechanisms.Materials today. Bio · 2026Review
- A Facile Strategy to Restore the Optic Nerve Functionality Using an Injectable Conducting Hydrogel.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
Abstract
This study introduces a novel injectable conductive polymer hydrogel from poly(3,4-ethylenedioxythiophene) (PEDOT). This hydrogel is designed to facilitate the recovery of electrophysiological function in injured optic nerves. The hydrogel can be injected directly at the injury site and spontaneously gel in place. These findings indicate a remarkable restoration of electrophysiological function, with a two to fourfold increase in amplitude (N1-P1 wavelet) of flash visual evoked potentials. Electroretinography results further support that both a-wave and b-wave amplitudes obtained under various adaptation conditions in the PEDOT hydrogel-treated animal models with optic nerve crush are comparable to those in the control group. The visual cliff testing results further supports the enhanced visual functionality after the hydrogel treatment. This improvement signifies enhanced responsiveness to light stimulation and a substantial boost in axonal transmission of visual information. Additionally, the injection of PEDOT hydrogel significantly mitigates the apoptosis of retinal ganglion cells, resulting in a fourfold increase in their survival rate. The ease of preparation and outstanding performance in vivo make it a promising bioengineered material for optic nerve research. This advancement offers new hope for patients with traumatic optic neuropathy, potentially leading to improved treatments and outcomes in optic nerve regeneration.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.